title: Safety and efficacy of zoledronic acid in multiple myeloma.
authors.forename: Athanassios
authors.initials: A
authors.lastname: Kyrgidis
authors.forename: Thrasivoulos-George
authors.initials: TG
authors.lastname: Tzellos
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D004002:Clodronic Acid / Q000008:administration & dosage / Q000009:adverse effects; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004347:Drug Interactions; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects; D015994:Incidence; D009101:Multiple Myeloma / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality; D010020:Osteonecrosis / Q000139:chemically induced / Q000453:epidemiology; D011379:Prognosis; D018570:Risk Assessment; D017751:Safety Management; D012720:Severity of Illness Index; D016019:Survival Analysis; D013923:Thromboembolism / Q000139:chemically induced / Q000453:epidemiology; D000077211:Zoledronic Acid; D016032:Randomized Controlled Trials as Topic
chemical_list: D004002:Clodronic Acid; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid